# Low Dose Naltrexone for Pain in Patients With HIV

> **NCT05537935** · PHASE4 · RECRUITING · sponsor: **Emory University** · enrollment: 60 (estimated)

## Conditions studied

- Human Immunodeficiency Virus
- Chronic Neuropathic Pain

## Interventions

- **DRUG:** Low Dose Naltrexone

## Key facts

- **NCT ID:** NCT05537935
- **Lead sponsor:** Emory University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-04-28
- **Primary completion:** 2027-06-30
- **Final completion:** 2027-06-30
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-04-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05537935

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05537935, "Low Dose Naltrexone for Pain in Patients With HIV". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05537935. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*